Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223828 · ClinicalTrials.gov registry record · Phase 2
Azithromycin for Critical Asthma - Pediatrics
A Phase 2 study of Critical Illness and Pediatric Asthma, sponsored by Johns Hopkins All Children's Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06223828 is a Phase 2 study of Critical Illness and Pediatric Asthma that is actively recruiting participants, run by Johns Hopkins All Children's Hospital. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06223828, a Phase 2 study of Critical Illness and Pediatric Asthma, is actively recruiting participants, sponsored by Johns Hopkins All Children's Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.
Conditions Studied
Interventions
- DRUG Azithromycin
Study Locations (1)
Florida
- Johns Hopkins All Children's Hospital - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-04-02 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06223828
The ClinicalTrials.gov registry entry for NCT06223828 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The listed sponsor is Johns Hopkins All Children's Hospital, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.
NCT06223828 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06223828 about?
NCT06223828 is a clinical study titled "Azithromycin for Critical Asthma - Pediatrics". The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.
What is the current status of trial NCT06223828?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2024-04-02. Estimated completion is 2026-12-31.
What conditions does trial NCT06223828 study?
This clinical trial studies the following conditions: Critical Illness, Pediatric Asthma.
What interventions are being tested in trial NCT06223828?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT06223828?
This trial is sponsored by Johns Hopkins All Children's Hospital, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223828 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The "What Is Important to Us" Communication Intervention Pilot Clinical Trial
RECRUITING · Phase 2
-
Practical Anemia Bundle for SusTained Blood Recovery
COMPLETED · Phase 2
-
Hypovitaminosis D in Neurocritical Patients
COMPLETED · Phase 2
-
Inulin for Infections in the Intensive Care Unit
COMPLETED · Phase 2
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.